The short-chain fatty acid receptor FFA2 plays a role in modulating beta cell responses to multiple low-dose streptozotocin via T1-IFN signaling. This suggests that FFA2 could be a therapeutic target in type 1 diabetes.
- Kai Xu
- Prabhakaran Kumar
- Medha Priyadarshini